Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2006-5-4
pubmed:abstractText
Poorly differentiated midline carcinoma with a translocation between chromosomes 15 and 19, i.e. t(15;19), has been recognized as a distinct clinical entity for over a decade. This tumor affects young individuals, shows a rapidly fatal clinical course despite intensive therapy. The t(15;19) results in the fusion oncogene BRD4-NUT. Information concerning treatment of this rare disorder is scarce.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1471-2407
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
69
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:16542442-Adult, pubmed-meshheading:16542442-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16542442-Back Pain, pubmed-meshheading:16542442-Carcinoma, pubmed-meshheading:16542442-Chromosomes, Human, Pair 15, pubmed-meshheading:16542442-Chromosomes, Human, Pair 19, pubmed-meshheading:16542442-Combined Modality Therapy, pubmed-meshheading:16542442-Epidural Space, pubmed-meshheading:16542442-Fatal Outcome, pubmed-meshheading:16542442-Female, pubmed-meshheading:16542442-Humans, pubmed-meshheading:16542442-In Situ Hybridization, Fluorescence, pubmed-meshheading:16542442-Lymphatic Metastasis, pubmed-meshheading:16542442-Mediastinal Neoplasms, pubmed-meshheading:16542442-Nuclear Proteins, pubmed-meshheading:16542442-Oncogene Proteins, Fusion, pubmed-meshheading:16542442-Polymerase Chain Reaction, pubmed-meshheading:16542442-Remission Induction, pubmed-meshheading:16542442-Respiratory Insufficiency, pubmed-meshheading:16542442-Sepsis, pubmed-meshheading:16542442-Spinal Neoplasms, pubmed-meshheading:16542442-Translocation, Genetic, pubmed-meshheading:16542442-Weight Loss
pubmed:year
2006
pubmed:articleTitle
Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.
pubmed:affiliation
Department of Oncology, Lund University Hospital, SE-221 85, Lund, Sweden. jens.engleson@skane.se
pubmed:publicationType
Journal Article, Case Reports, Research Support, Non-U.S. Gov't